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reproduction in any medium, provided the original author and source are credited.SUMMARYSOX2 is involved in several cell and developmental processes, including maintenance of embryonic stem cells, differentiation of neural
progenitor cells, and patterning of gut endoderm. To study its role in a human system, we generated a human embryonic stem cell (hESC)
line harboring a reporter gene encoding GFP in the SOX2 locus. This SOX2 reporter line faithfully recapitulates expression of the SOX2
gene in undifferentiated human pluripotent stem cells (hPSCs), neural progenitor cells (NPCs), and anterior foregut endoderm (AFE). In
undifferentiated hESCs, GFP expression corresponds to those cells with highest levels of expression of genes associated with the plurip-
otent state. In NPCs, expression of GFP can be employed to isolate cells expressingmarkers associatedwithNPCmultipotency. In AFE, we
used transcriptome-wide expression analysis to identify cell surface markers with elevated expression in this population, thereby facili-
tating isolation and purification of this hPSC-derived cell population.INTRODUCTION
Human pluripotent stem cells (hPSCs; including human
embryonic stem cells [hESCs] and human induced plurip-
otent stem cells [hiPSCs]), provide a unique model system
to study early human development and generate mature
and functional cell types suitable for disease modeling,
cell transplantation, and replacement therapies. Clinical
applications of hPSCs will require a detailed understanding
of the mechanisms that maintain their pluripotency or
result in their differentiation to specific lineages. A partic-
ularly attractive method to study the underlying mecha-
nisms that control pluripotency and differentiation is
through the use of marker cell lines in which specific genes
known to function in these processes are modified with a
‘‘molecular beacon,’’ such as a gene encoding a fluorescent
protein. Expression of such a tagged gene can be used to
analyze and characterize the cells in which expression of
this gene is either activated or repressed. Here, we describe
the generation and characterization of such a marker line
for the gene SOX2, which plays multiple roles in hPSC plu-
ripotency and differentiation (Arnold et al., 2011; Lefebvre
et al., 2007).
SOX2 is a member of the SRY-related high-mobility-
group box (SOX) transcription factors and controls cell
fate and differentiation in a variety of cell types during
development (Kiefer, 2007; Lefebvre et al., 2007). During
the initial stages of development, SOX2 is expressed in
the inner cell mass of the blastocyst (Lorthongpanich464 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 Theet al., 2008; Rossant, 2004) and along with OCT4 is
responsible for regulating the pluripotent precursors that
develop into the three germ layers (Avilion et al., 2003).
SOX2 acts in coordination with other factors, such as
NANOG (Wang et al., 2006) and OCT4 (Nichols et al.,
1998), to maintain ESCs in a pluripotent state. Further-
more, ectopic expression of SOX2 along with OCT4,
KLF4, and c-MYC can induce a pluripotent stem cell state
from adult human fibroblasts, giving rise to hiPSCs (Taka-
hashi et al., 2007).
In addition to regulating the pluripotent state, SOX2
controls the formation of several cell types during fetal
development, such as the nervous system (Ellis et al.,
2004), anterior foregut endoderm (Que et al., 2007),
and sensory cells of the taste bud and inner ear (Dab-
doub et al., 2008; Kiernan et al., 2005; Okubo et al.,
2006). SOX2 also regulates the progenitor cells in several
adult tissues in the brain (Ellis et al., 2004), trachea
(Que et al., 2009), and pituitary glands (Fauquier
et al., 2008). A recent genetic lineage tracing study re-
vealed that SOX2 regulates adult stem cells and tissue
homeostasis in several adult epithelial tissues in the
stomach, cervix, anus, testes, lens, and glands associated
with the oral cavity, trachea, and cervix (Arnold et al.,
2011).
In this study, we describe the generation and character-
ization of a hESC line in which the endogenous SOX2 locus
was targeted to express GFP. The targeted reporter line facil-
itated the flow-cytometry-based purification and geneticAuthors
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Figure 1. Generation and Characteriza-
tion of SOX2-GFP Clones
(A) Schematic of SOX2-GFP-targeting
strategy. The top diagram represents the
rAAV targeting vector used for targeting of
the SOX2 locus. The middle diagram depicts
the genomic locus of SOX2, a single exon
gene, and the bottom diagram illustrates
the properly targeted SOX2 locus. The
genetic elements are not displayed to scale.
(B) Southern blot using probe-1 (see dia-
gram in [A])-confirmed targeting of the GFP
gene to the endogenous SOX2 locus in
hSOX2-23 (23). The bands specific to the
targeted allele are not observed in non-
targeted wild-type cells (H9). Blots hy-
bridized with probe 2 as well as uncropped
blots can be found in Figure S1.
(C) Using fluorescence-based cell sorting,
undifferentiated hSOX2-23 hESCs were
separated on the basis of GFP expression.
Wild-type (WT) nonfluorescing H9 hESCs
were used as a control to set gates for cell
sorting. NFC, nonfluorescent channel.
(D) Gene expression analysis by quantita-
tive RT-PCR (qRT-PCR) reveals that plurip-
otency markers SOX2, OCT4, and NANOG were
enriched in the GFP+ population. Data
represent the mean ± SEM from three
independent sorting experiments. Pop-
ulations were compared using Student’s t
test. The asterisk denotes p < 0.05.
(E) Representative images of GFP,
a-NANOG, and a-OCT4 IF of GFP+ and GFP
cells (scale bar represents 200 mm).
See also Figures S1 and S2.
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SOX2 Expression in Human Pluripotent Stem Cellsassessment of SOX2-positive (SOX2+) cells in pluripotent
hESCs as well as hESC-derived neural progenitor cells
(NPCs) and anterior foregut endoderm (AFE). Genome-
wide analysis of SOX2+ AFE cells revealed a global gene
expression signature that distinguished hESC-derived AFE
cells from other cell types. This signature included two
cell surface markers that permitted purification of SOX2+
AFE cells from differentiating hESC cultures. Therefore,
this SOX2-GFP reporter line is a valuable tool to dissect
the role of SOX2 in regulating pluripotency, self-renewal,
and differentiation.Stem Cell RRESULTS
Generation of a SOX2-GFP Reporter hESC Line by AAV
Mediated Homologous Recombination
Using a recombinant adeno-associated viral (rAAV)-based
gene-targeting method, we inserted the gene-encoding
GFP into the SOX2 locus in H9 hESCs (Figure 1A). Proper
homologous recombination led to the replacement of
the SOX2 open reading frame with that of GFP and a
neomycin selection cassette (SV40-Neo). After infection
with rAAV and G418 drug selection, a total of 36 cloneseports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 465
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Figure 2. Differentiation of SOX2-GFP hESC to Neurectoderm Lineages
(A) Outline of protocol for differentiation of hESCs to NPCs. The soluble factors, substrate, and culture media at each stage are indicated.
KO, knockout; KSR, KnockOut serum replacement.
(legend continued on next page)
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SOX2 Expression in Human Pluripotent Stem Cellswere expanded and screened by Southern blotting for ho-
mologous recombination events. Among these clones, 26
(72%) were found to carry the GFP-Neo cassette in the
SOX2 locus (Figure S1A available online). No clones in
which both SOX2 alleles were disrupted were isolated.
Our subsequent analysis focused on one of these clones,
clone 23 (hSOX2-23). We confirmed appropriate gene
targeting in this clone using multiple restriction digests
followed by Southern blotting (Figures 1B, S1B, and
S1C). We did not observe nontargeted insertions of the
rAAV sequences, and cells exhibited a normal karyotype
(data not shown). Flow cytometry of hSOX2-23 revealed
that the majority of the cells expressed GFP (Figure 1C).
By comparison, a drug-selected clone, hSOX2-25, which
was negative for targeted insertion (Figure S1A), showed
no detectable GFP (Figure S2A). Despite only having one
copy of SOX2, hSOX2-23 had similar levels of SOX2,
OCT4, and NANOG expression as hSOX2-25 and wild-
type (WT) hESCs (Figure S2B). Moreover, the percentage
of GFP-positive (GFP+) cells in hSOX2-23 was constant
over more than 20 passages. Immunofluorescence (IF)
staining of hSOX2-23 showed that 100% of GFP+ cells
expressed SOX2 protein (Figure S2C). Additionally,
hSOX2-23 colonies had characteristic hESC morphology
(Figure S2D) and expressed markers of the undifferentiated
state, such as NANOG (Figure S2E). These results show that
this rAAV-based gene-targeting method can be used to effi-
ciently disrupt genes by homologous recombination. In
addition, the SOX2-GFP hESC marker line can be used to
monitor SOX2 expression in undifferentiated hESCs.
SOX2-GFP Marks Undifferentiated hESCs
To investigate whether GFP expression in hSOX2-23 could
be used to monitor the differentiation status of hESCs, we
performed flow cytometry analysis of hSOX2-23 grown in
culture conditions that maintain hESCs in an undifferenti-
ated state. In these conditions, >90% of the cells were GFP+
(Figure 1C). Quantitative RT-PCR (qRT-PCR) revealed that
expression of SOX2, OCT4, and NANOG was significantly(B) Gene expression analysis for the neurectoderm marker PAX6 dur
experiments; error bars represent ± SEM; **p < 0.01).
(C) Flow cytometry analysis of TRA1-81 and GFP during NPC different
(D) IF analysis of GFP and SOX2 showed colocalization in NPCs (scale
(E) Flow cytometry analysis of SOX1 expression in SOX2-GFP NPCs. SOX1
in Table S4.
(F) IF of SOX2-GFP hESCs differentiated to neural rosettes (scale bar
(G) SOX2-GFP neural rosette cells were sorted on the basis of GFP exp
sorting.
(H) Gene expression analysis of sorted GFP+ and GFP cells showed hig
cells. Data represent the mean ± SEM from three independent sorting
asterisk denotes p < 0.05 and double asterisks denote p < 0.01.
(I) Flow cytometry analysis of SOX1 expression in FACS-purified GFP+
SOX1.
Stem Cell Rhigher in GFP+ compared to GFP negative (GFP) cells (Fig-
ure 1D), indicating thatGFP expressionmarked undifferen-
tiated cells. To determine if GFP expression could be used to
remove differentiating cells from pluripotent hESC cul-
tures, we cultured purified GFP+ and GFP cells in condi-
tions that support undifferentiated growth for hESCs.
The GFP+ cells grew as compact colonies characteristic of
the undifferentiated state, whereas the GFP cells had a
fibroblast-like morphology typical of differentiating hESCs
(Figure S2F). Moreover, cultured GFP+ cells maintained
high GFP expression, whereas cultured GFP cells failed
to express detectable levels of GFP (Figure 1E). Finally, IF
staining revealed that cultured GFP+ cells maintained
high NANOG and OCT4 expression, whereas cultured
GFP cells showed little NANOG or OCT4 expression
(Figure 1E). These results suggest that the SOX2-GFP
marker can be used to monitor the undifferentiated state
of hESCs.
Dynamics of SOX2-GFP Expression during Neural
Differentiation
In addition to being a master regulator of hPSCs, SOX2 is a
marker of multipotent NPCs and is necessary for their
maintenance in the nervous system (Ellis et al., 2004).
To assess regulation of the SOX2-GFP marker during neu-
rectoderm differentiation, we developed a serum-free dif-
ferentiation protocol based on previously published
methods (Figure 2A; Chambers et al., 2009; Li et al.,
2011). In brief, NPCs were manually picked from
embryoid body-derived rosettes, dissociated, replated,
and maintained as proliferative cells in the presence of
fibroblast growth factor 2 (FGF2) and epidermal growth
factor (EGF) (Shin et al., 2006). Expression of SOX2 and
the neural-specific marker PAX6 peaked upon NPC forma-
tion (Figure 2B). Flow cytometry confirmed the progressive
loss of the pluripotency marker TRA-1-81 as hESCs differ-
entiated to rosettes and NPCs (Figure 2C). Concurrently,
GFP expression declined upon differentiation to the
rosette stage and then re-emerged in NPCs (Figure 2C).ing hESC differentiation to rosettes and NPCs (n = 3 independent
iation. Isotype controls used are listed in Table S4.
bar represents 100 mm).
shows high coexpression with GFP. Isotype controls used are listed
represents 500 mm).
ression. WT H9 rosettes were used as a control to set gates for cell
h expression of NPC markers SOX2, SOX1, NESTIN, and PAX6 in GFP+
experiments. Populations were compared using Student’s t test. The
cells. Replated GFP+ cells maintained high expression of GFP and
eports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 467
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SOX2 Expression in Human Pluripotent Stem CellsThis pattern of GFP expression is consistent with previous
studies (Chambers et al., 2009). IF of hSOX2-23 NPCs re-
vealed that 100% of GFP+ NPCs were SOX2+ (Figure 2D).
Additionally, a high percentage of GFP+ NPCs coexpressed
the NPC marker SOX1 as monitored by flow cytometry
(Figure 2E). Together, these results demonstrate that
SOX2-GFP expression can be used to monitor neural dif-
ferentiation of hESCs.
Isolation of SOX2-GFP+ NPCs from Neural Rosettes
Fluorescence analysis of rosette stage cultures revealed
that GFP expression was isolated to the neuroepithelial-
like rosette structures that are manually dissected to
obtain NPCs (Elkabetz et al., 2008; Figure 2F). To investi-
gate if GFP expression could allow for the isolation of
NPCs without manual dissection, we dissociated rosette-
stage cultures into single cells and isolated GFP+ cells
using fluorescence-based cell sorting (Figure 2G). Gene
expression analysis of GFP+ and GFP cell populations
by qRT-PCR revealed that the GFP+ rosette stage cells ex-
pressed higher amounts of the NPC markers SOX1,
SOX2, PAX6, and NESTIN than the GFP rosette stage cells
(Figure 2H). Subsequent culture of GFP+ rosette stage cells
revealed that these cells maintained high expression of
GFP and the NPC marker SOX1 (Figure 2I). Thus, SOX2-
GFP expression can be used to isolate NPCs from rosette
stage cultures.
SOX2-GFP Marks the Anterior Foregut Endodermal
Progeny of Differentiating hESCs
SOX2 is expressed in the developing AFE, with the highest
levels in the future esophagus, trachea, and lung (Que et al.,
2007). To investigate if the hSOX2-23 line could be used to
isolate cells with an AFE identity from differentiating
hESCs, we used a modified version of previously published
protocols (Figure 3A; Green et al., 2011; Longmire et al.,
2012; Mou et al., 2012). To generate definitive endoderm
(DE), the precursor cell population for AFE, hSOX2-23s
were treated with Activin A and Wnt3a (stage 1). Subse-
quent differentiation to AFE was achieved through addi-
tion of bone morphogenetic protein (BMP) antagonists
noggin and SB431542 (stage 2). Maturation to a lung pro-
genitor cell (LPC) phenotype was achieved through addi-
tion of BMP4, FGF2, and Wnt3a. At stage 1, expression of
the DE marker SOX17 peaked while expression of the plu-
ripotency marker NANOG declined (Figure 3B). Similarly,
at stage 2, we observed high expression levels of AFE
markers FOXA2 and TBX1 (Figure 3B). In contrast, expres-
sion of the posterior foregut endoderm (PFE) markersHNF6
and PDX1was not detectable (Figure S3A). SOX2, as well as
TBX1, expression re-emerged during differentiation to AFE
(Figure 3B), but not to PFE (Figure S3B), suggesting the
SOX2-GFP reporter line can be employed to isolate cells468 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 Thewith properties associated with AFE. Furthermore, LPC
markers NKX2.1 and SOX9 showed high levels of expres-
sion at stage 3 (Figure 3B). Consistent with previous
publications, this protocol yielded approximately 25%
NKX2.1-positive (NKX2.1+) LPCs (Figure 3C).
Next, we tested whether GFP expression in hSOX2-23
hESCs could be used to monitor anterior foregut differen-
tiation and to purify AFE progeny. After an initial decrease
in GFP expression as cells exited the pluripotent state and
differentiated toward DE, a GFP+ cell population re-
emerged and expanded during the AFE stage (Figure 4A).
Upon subsequent differentiation to LPC, GFP expression
disappeared. This temporal pattern of GFP expression
was consistent with our analysis of SOX2 gene expression.
Differentiation of hSOX2-23 into AFE yielded densely
packed GFP+ cells, often surrounding an empty lumen-
like cavity (Figure 4B). qRT-PCR analysis revealed that
expression of the AFE markers SOX2, TBX1, PAX9,
HOXA1, and HOXA2was highly enriched in the GFP+ pop-
ulation, whereas the PFE markers HNF1B, HNF4A, GATA6,
CDX2, and PDX1 were enriched in the GFP population
(Figure 4C). To test the potential of these cells to develop
into LPCs, sorted GFP+ and GFP AFE cells and unsorted
control AFE cells were replated and differentiated to LPCs
using previously described methods (Green et al., 2011;
Longmire et al., 2012; Mou et al., 2012). IF analysis for
NKX2.1, the earliest marker of LPCs distinguishing it
from the remainder of the AFE (Fagman et al., 2011; Que
et al., 2009), revealed that >90% of GFP+ cells differenti-
ated into NKX2.1+ lung endoderm (Figure 4D). In contrast,
the unsorted AFE population or the GFP populations
generated significantly fewer SOX2+ and NKX2.1+ cells
(Figure 4D). Together, these results demonstrate that
GFP+ cells exhibit properties of AFE and are capable of
differentiating in vitro into derivatives of AFE, including
NKX2.1+ LPCs.
Genome-wide Analysis of SOX2-GFP Reporter-
Expressing Anterior Foregut Endoderm Cells
To define a global gene expression signature of AFE, we per-
formed whole transcriptome sequencing (RNA sequencing
[RNA-seq]) of sorted GFP+ and GFP cells from differenti-
ated AFE cultures (Figure 5A and Table S1). We identified
1,943 genes with differential expression between these
two cell populations, with the expression of 1,038 genes
elevated in the GFP+ population and 905 genes elevated
in theGFP population (Figure 5B). This signature included
genes involved in signaling pathways (Wnt, FGF, Notch,
BMP, and RA signaling) known to play a role in the
patterning of the foregut endoderm.Moreover, this genetic
signature included genes known to define developing AFE
and PFE (Figure 5C). Specifically, expression of AFEmarkers
SOX2, HOXA1, HOXA2, and IRX5 was highly enriched inAuthors
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Figure 3. Differentiation of hESCs to
Anterior Foregut and Lung Endoderm
(A) Outline of protocol for differentiation of
hESCs to anterior foregut and lung progen-
itor cells. The soluble factors and culture
media at each stage are shown.
(B) Gene expression analysis of markers of
undifferentiated hESCs (NANOG, SOX2),
definitive endoderm (DE; SOX17), anterior
foregut endoderm (AFE; SOX2, FOXA2,
TBX1), and lung progenitor cell (LPC;
NKX2.1, SOX9; n = 3 independent experi-
ments; error bars represent ± S.E.M; *p <
0.05; **p < 0.01).
(C) IF for NKX2.1 on day 13 LPC cultures
(mean ± SD; scale bar represents 200 mm).
See also Figure S3.
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SOX2 Expression in Human Pluripotent Stem Cellsthe GFP+ population (Figure 5C). Conversely, expression of
PFE markers HNF1A, HNF1B, HNF6, and GATA6 as well as
the DE markers SOX17 and FOXA1 were increased in the
GFP cells (Figure 5C). Early markers of tissues derived
from AFE, such as the lung (IRX1 and SOX9), thyroid
(PAX8), pharynx (FGF8), esophagus (DLX3 and OTX1),
and stomach (EYA4), showed higher levels of expression
in GFP+ cells (Figure 5C). In contrast, expression of genes
associated with tissues derived from PFE, such as intestine
(CDX2), liver (AFP), and pancreas (PDX1 and NGN3),
were lower in GFP+ cells (Figure 5C). Collectively, this
RNA-seq analysis suggests that GFP+ cells isolated from
differentiating cultures are enriched for cells with an AFE
gene expression profile.Stem Cell RIsolation of AFE Using Cell Surface Markers
To develop a cell surface marker ‘‘signature’’ for SOX2+ AFE
cells, wemined our RNA-seq data for genes encoding trans-
membrane proteins with differential expression levels be-
tween GFP+ and GFP cells (Table S2). qRT-PCR confirmed
that several genes encoding cell surfacemarkers were differ-
entially expressed in the GFP+ and GFP populations (Fig-
ures S4A and 4B). Flow cytometry with antibodies directed
against these cell surface markers revealed that staining of
CD56 (neural cell adhesion molecule [NCAM]) and
CD271 (nerve growth factor receptor [NGFR]) correlated
with GFP expression in day 8 AFE cells (Figures 6A and
6B, and S4C). Consistent with the RNA-seq data, qRT-
PCR analysis confirmed that transcripts for both CD56eports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 469
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Figure 4. Characterization of SOX2-GFP
Reporter hESCs Differentiation to AFE
(A) Flow cytometry analysis of SOX2-GFP
dynamics during hESC differentiation to AFE
and LPC.
(B) IF analysis of day 8 SOX2-GFP AFE cul-
tures (scale bar represents 200 mm).
(C) Gene expression analysis showed that
AFE markers (SOX2, TBX1, PAX9, HOXA1,
HOXA2) were highly enriched in GFP+ cells.
The expression levels of markers of the
posterior foregut endoderm (PFE; HNF1B,
HNF4A, GATA6, CDX2, PDX1) were higher in
GFP cells (n = 3 independent experiments;
error bars represent ± SEM).
(D) IF analysis of GFP+, GFP, or unsorted
control cells that were purified using fluo-
rescence-based cell sorting at day 8 of dif-
ferentiation, replated, and differentiated to
LPCs. Expression of GFP and the LPC marker
NKX2.1 was enriched in in-vitro-differenti-
ated GFP+ cells versus GFP or unsorted
control cells (mean ± SD; scale bar repre-
sents 200 mm).
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SOX2 Expression in Human Pluripotent Stem Cellsand CD271 were enriched in the GFP+ populations (Fig-
ure S4B). Similarly, gene expression analysis of cells at
various stages of differentiation revealed that CD56 and
CD271 expression peaked at AFE (Figure S4D).
Using fluorescence-based cell sorting of day 8 AFE
cultures with antibodies to CD56 and CD271 (Figures 6A
and 6C), we demonstrated that double-positive
CD56+CD271+ cells expressed higher levels of GFP than
single-positive CD56+CD271 or CD56CD271+ cells or
double-negative CD56CD271 cells (Figure 6D). When
AFE cells differentiated from WT H9 hESCs were sorted
for these cell surface markers, expression of AFE markers
SOX2, TBX1, and PAX9 was increased in double-positive
cells compared with double-negative cells (Figure 6E).
Conversely, expression of PFE markers GATA6, HNF1B,470 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 TheHNF4A, CDX2, and PDX1 was higher in double-negative
cells compared with double-positive cells (Figure 6E). To
investigate if double-positive CD56+CD271+ cells were
capable of differentiating into more mature lung progeny,
as assessed by NKX2.1 expression, we replated CD56+
CD271+ and CD56CD271 cells after cell sorting and
differentiated them to LPCs. Gene expression analysis re-
vealed that expression of the LPC markers NKX2.1 and
SOX9 was enriched in the CD56+CD271+ population rela-
tive to the CD56CD271 (Figure 6F). Additionally, IF anal-
ysis for NKX2.1 revealed that a higher percentage of the
CD56+CD271+ cells differentiated into NKX2.1+ lung
endoderm compared to the CD56CD271 cells (Fig-
ure 6G). Interestingly, cells with highest NKX2.1 expres-
sion were clustered with bright staining along the edges,Authors
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See also Table S1.
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SOX2 Expression in Human Pluripotent Stem Cellsan organization reminiscent of an epithelial cell popula-
tion as may be expected for lung epithelial precursors.
These data demonstrate that cell enrichment strategies
for CD56 and CD271 significantly increase the percentage
of cells with AFE gene expression patterns from differenti-
ated hESC cultures.
Although our analysis suggested that CD56 and CD271
marked SOX2+ AFE cells, it was unclear if these cell surface
markers specified SOX2+ cells in undifferentiated hESC or
neurectoderm cultures. Gene expression analysis revealed
that neither CD56 nor CD271 expression was enriched in
GFP+ hESCs (Figure 7A) or neural rosette cells (Figure 7B).Stem Cell RFlow cytometry revealed that neither CD56 nor CD271
correlated with GFP expression in hESCs (Figure 7C) or neu-
ral rosette cells (Figure7D). Because SOX2 is also expressed in
undifferentiated hESCs and neurectoderm cells, we wanted
to confirm that we were not enriching these rare cell types
in our CD56+CD271+ AFE cultures. To that end, there was
little expression of the pluripotency markers OCT4 and
NANOG in CD56+CD271+ AFE cells when compared to
undifferentiated hESCs (Figure 7E). Additionally, there was
no difference in expression of these genes between the
CD56+CD271+ and CD56CD271 AFE cells. Furthermore,
expression of the neurectoderm markers SOX1, PAX6, andeports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 471
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Figure 6. Cell Surface Markers Expressed
in hESC-Derived AFE
(A) HESC-differentiated AFE cells were sor-
ted based on levels of CD56 and CD271
expression. Double-positive CD56+CD271+
and double-negative CD56CD271 cells
were replated and further differentiated
in vitro to LPCs.
(B) Flow cytometry analysis demonstrated
that CD56 and CD271 expression correlates
with GFP expression in day 8 AFE SOX2-GFP
cells.
(C) HESC-differentiated AFE cells were sor-
ted on the basis of CD56 and CD271.
(D) Flow cytometry analysis shows that
GFP expression is highest in double-
positive CD56+CD271+ compared to single-
positive CD56+CD271 or CD56CD271+
cells or double-negative CD56CD271
cells.
(E) Gene expression analysis reveals that the
expression of the AFE markers SOX2, TBX1,
and PAX9 were highly enriched in the
CD56+CD271+ cells. As expected, expres-
sion of CD56 and CD271 was enriched in
CD56+CD271+ cells. Conversely, expression of
the PFEmarkers GATA6, HNF1B, HNF4A, CDX2,
and PDX1 were enriched in CD56CD271
cells.
(F) Expression of LPC markers NKX2.1 and
SOX9 was enriched in in-vitro-differ-
entiated CD56+CD271+ cells. Data represent
the mean ± SEM from three independent
sorting experiments. Populations were
compared using Student’s t test. The
number sign denotes p > 0.05, asterisk
denotes p < 0.05, and double asterisks
denote p < 0.01.
(G) IF analysis of CD56+CD271+ and
CD56CD271 cells that were purified by
fluorescence-based cell sorting at day 8, replated, and differentiated to LPCs. Expression of the LPC marker NKX2.1 was enriched in in-vitro-
differentiated CD56+CD271+ cells versus CD56CD271 cells (scale bar represents 200 mm).
See also Figures S4 and Table S2.
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SOX2 Expression in Human Pluripotent Stem CellsNES was significantly lower in CD56+CD271+ AFE cells
compared to neural rosette cells (Figure 7F). Finally, there
was no difference in expression of these genes among the
CD56+CD271+ and CD56CD271 AFE cells. Collectively,
these studies suggest that CD56 and CD271 expression
correlates only with the SOX2+ AFE cell population.DISCUSSION
In this work, we employed a human SOX2-GFP reporter cell
line to characterize distinct cell populations inwhich SOX2
is known to be expressed, including undifferentiated472 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 ThehPSCs, NPCs, and anterior foregut endodermal cells
(AFEs). We showed that this reporter line can be used to
monitor the differentiation status of cells, isolate andpurify
distinct cell populations, and identify genes with expres-
sion patterns associated with these distinct cell popula-
tions. This approach is particularly valuable for the design
and development of protocols for the directed differentia-
tion of hPSCs into cell populations suitable for transplanta-
tion studies, disease modeling, and drug screening.
Gene Targeting Using AAV
Gene targeting in hPSCs has met many challenges, and to
date, methods for homologous recombination (HR) inAuthors
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Figure 7. CD56 and CD271 Do Not Mark a SOX2+ hESC or Neural Population
Gene expression analysis of GFP+ and GFP undifferentiated hESCs (A) and neural rosette cells (B) shows that expression of CD56 and CD271
is not enriched in GFP+ or GFP cell populations (n = 3 independent experiments; error bars represent ± SEM, #p > 0.05). Flow cytometry
analysis demonstrates that CD56 and CD271 do not correlate with GFP expression in undifferentiated hESCs (C) and neural rosettes (D).
Double-positive CD56+CD271+ AFE cells are not enriched for hESC- (E) or neural- (F) related markers (n = 3 independent experiments; error
bars represent ± SEM; **p < 0.01. DP, double-positive CD56+CD271+ AFE; DN, double-negative CD56CD271 AFE; NS, no statistically
significant difference).
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SOX2 Expression in Human Pluripotent Stem CellshPSCs are not as commonplace as in mouse embryonic
stem cells (mESCs). The reasons for differences in gene tar-
geting between mESCs and hPSCs remain poorly under-
stood. It has been suggested that mESCs represent an early
‘‘naive’’ developmental stage akin to the inner cell mass of
the blastocyst, whereas hPSCs represent a later ‘‘primed’’
developmental state that resembles the epiblast (Nichols
and Smith, 2009), and that this difference accounts forStem Cell Rthe differences observed in transgenesis and HR (Buecker
et al., 2010). In fact, Buecker et al. showed that, in hPSCs
that had been genetically manipulated to obtain a naive
mESC-like state, HR targeting efficiencies approached
those typically observed in mESCs (Buecker et al., 2010).
However, conversion of hPSCs to a naive state with biolog-
ical characteristics similar to mESCs remains technically
challenging (Hanna et al., 2010).eports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 473
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SOX2 Expression in Human Pluripotent Stem CellsBased on several previous publications (Khan et al., 2010,
2011), we explored the utility of adeno-associated virus
(AAV) as a method to improve gene targeting efficiencies
in hPSCs. For SOX2, a gene that is highly expressed in un-
differentiated hPSCs, gene targeting rates were greater than
70%. Similar targeting efficiencies in hPSCs using AAV
have been reported by others (Asuri et al., 2012; Khan
et al., 2010, 2011; Smith-Arica et al., 2003), indicating
that AAV offers a highly efficient and robust approach to
target genes for HR in hPSCs.
Currently, conventional methods for gene targeting uti-
lize standard transduction methods, such as electropora-
tion, to introduce linearizedDNAconstructswithhomology
arms of 3–5 kb flanking positive (e.g., neomycin or hygrom-
ycin) and negative (ganciclovir) selection cassettes
(Mansour et al., 1988). These approaches are extremely inef-
ficient, with targeting efficiencies varying between <0.1%
and 5%. An alternative method to improve gene modifica-
tion efficiencies involves the introduction of site-specific,
double-stranded breaks into the genome using zinc finger
nucleases (Davis and Stokoe, 2010; Zou et al., 2009), tran-
scription activator-like effector nucleases (Hockemeyer
et al., 2011), or the RNA-guided CRISPR-Cas system (Cong
et al., 2013;Houetal., 2013;Mali et al., 2013).Whereas these
approaches are promising, site-directed specificity has been
difficult to control and off-target cleavage events are com-
mon (Cradick et al., 2013; Radecke et al., 2010). In addition,
bacterial artificial chromosomes (BACs) have been success-
fully used for site-specific targeting in hPSCs at efficiencies
of up to 25% (Song et al., 2010); however, the use of BACs
is technically challenging due to complex cloningmethods.
In contrast to these methods, AAV offers features that
make it an attractive alternative means for gene targeting.
First, the AAV genome is relatively compact (4.8 kb) and
genetic engineering is accordingly straightforward. Aside
from two flanking palindromic inverted terminal repeats,
the entire genome can be engineered to contain the desired
genetic elements, including drug selection cassettes, re-
porter genes, and homology arms to promote HR. Second,
AAV is a single-stranded DNA virus and, upon infection
and entry into the cell, this single-stranded piece of DNA
provides an ideal substrate for the endogenous DNA repair
machinery, thereby significantly increasing gene-targeting
efficiencies. Third, AAV rarely integrates itself nonspecifi-
cally into the genome and it consequently has become an
attractive system to create viral vectors for gene therapy.
SOX2, a Regulator of Pluripotency
Along with OCT4 and NANOG, SOX2 is one of the master
regulators of the pluripotent state in hPSCs (Rizzino,
2009). However, analysis of SOX2 expression in hPSCs re-
lies on the fixation of cells, which limits their use in subse-
quentmolecular and biological studies.Wewere able to use474 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 Theour SOX2-GFP reporter line to detect and enrich for SOX2
expression in live hPSC cultures. Consistent with previous
reports that describe hPSCs as heterogeneous cultures with
varying levels of expression of pluripotency-associated
genes (Stewart et al., 2006), we observed varying levels of
SOX2-GFP expression in our hPSC cultures. Purification
and analysis of these cells revealed higher expression levels
of pluripotency-associated genes in SOX2+ versus SOX2
cells. Moreover, subsequent culture of purified SOX2+ and
SOX2 cells revealed that they maintained distinct devel-
opmental states.
SOX2, a Regulator of NPC Multipotency
NPCs derived from hPSCs offer a unique model system to
study neural development and are a possible source of cells
to treat a variety of neurodegenerative disorders. In the
adult brain, SOX2 functions to maintain the multipotent
state of endogenous NPCs (Graham et al., 2003). Further,
SOX2 is a marker of multipotent NPCs derived from hPSCs
(Chambers et al., 2009; Li et al., 2011). Consistent with
these studies, we were able to use SOX2-GFP reporter
expression to isolate a homogeneous population of
SOX2+ NPCs from heterogeneously differentiating cul-
tures. Moreover, we demonstrated that these cells were en-
riched for neural markers and maintained high expression
of NPC markers over subsequent passages. These SOX2+
NPCs will be useful for future applications, such as neural
transplantation, genetic profiling, or epigenetic analysis.
SOX2, a Marker of Gut Tube Patterning
Cells derived from AFE, including those comprising the
lung, trachea, and thyroid, are of significant interest for
many regenerative medicine and disease-modeling pur-
poses. SOX2 has been implicated in regulating the
patterning of the foregut endoderm along the anterior-pos-
terior axis and specifying AFE (Que et al., 2007). Using our
SOX2-GFP reporter line, we were able to monitor foregut
endoderm differentiation and use flow cytometry to isolate
a pure SOX2+ AFE population from differentiating cultures
and perform subsequent genetic and developmental
studies. Using RNA-seq, we were able to identify a global
gene expression signature that defines SOX2+ AFE cells in
heterogeneously differentiating hPSC cultures. Because
AFE exists only transiently during in vivo development,
our SOX2 reporter line allows for the in vitro study of a
developmental stage that is difficult to analyze in vivo.
Finally, we demonstrated that subsequent in vitro differen-
tiation of sorted SOX2+ cells led to the generation of cells
that uniformly express NKX2.1, a transcriptional regulator
of lung and thyroid development. Together, this cellular
platform will be useful for future studies examining the
developmental and genetic programs that contribute to
foregut, lung, and thyroid development.Authors
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SOX2 Expression in Human Pluripotent Stem CellsFlow-cytometry-based purification of intermediate pro-
genitor cell populations of differentiating hPSCs followed
by subsequent differentiation is an alternative approach
for generating highly enriched and well-defined mature
cell populations required for cell-based therapies and
disease modeling (McKnight et al., 2010). Recently, trans-
genic cell marking combined with genome-wide expres-
sion profiling and flow cytometry have been used to
develop flow-cytometry-based strategies for the purifica-
tion of DE, immature cardiomyocytes, and pancreatic
endoderm (Dubois et al., 2011; Kelly et al., 2011; Wang
et al., 2011). However, flow-cytometry-based strategies
have not yet been developed for the purification of AFE.
Using our genome-wide expression analysis of reporter-
expressing AFE cells, we identified two cell surface
markers, CD56 (also known as NCAM) and CD271 (also
known as NGFR), that permitted the isolation of SOX2+
AFE cells. Although their names imply neural expression
(and hence ectodermal origin), CD56/NCAM and
CD271/NGFR are not completely restricted to the deriva-
tives of the ectodermal germ layer. For example, these cell
surface markers also define cells of the mesodermal (Ev-
seenko et al., 2010), mesenchymal (Saliem et al., 2012),
and other nonneural lineages (Yuan et al., 2011). In the
future, this cell surface panel will allow for the prospective
isolation and study of pure AFE cells from potentially any
hPSC line.
In conclusion, we have developed a cell-based tool that
will allow for the study of SOX2+ cells, not only in pluripo-
tent hPSCs, but also in various endodermal and neural-
related cell types. Furthermore, this reporter cell line will
enable high-throughput screening approaches to identify
secreted factors or small molecules that promote endo-
dermal or neural differentiation of hPSCs. Finally, because
SOX2 is one of the few regulatory genes expressed in both
pluripotent and differentiated cells, future genetic and
epigenetic analysis of the SOX2+ cell populations will allow
for the identification of commonmechanisms that control
hPSC pluripotency and differentiation.EXPERIMENTAL PROCEDURES
Cells and Culture Conditions
Media compositions and sources for all cell lines are listed in the
Supplemental Information section. All hESC cultures were supple-
mented with 30 ng/ml FGF2. Mouse embryonic fibroblast-condi-
tioned medium (MEF-CM) was produced by culturing MEFs in
hESC medium for 24 hr followed by sterile filtering. Cells were
routinely passaged with Accutase, washed, and replated at a den-
sity 4.25 3 104/cm2. All work with hESCs was reviewed and
approved by the University of California at San Diego (UCSD)
Stem Cell Research Oversight Committee, project numbers
100210ZX and 090807ZX.Stem Cell RAAV Production and Gene Targeting
The design and construction of the SOX2-targeting vector is
described in the Supplemental Experimental Procedures. Superna-
tants carrying infectious AAV particles were produced as previ-
ously described (Hirata et al., 2002) with a detailed protocol avail-
able here: http://vectorcore.salk.edu/protocols/AAV Production
Protocol.doc. H9 cells on Matrigel in MEF-CM were infected
with the SOX2-GFP AAV-2 supernatants at approximately 1010
genome copies. After 24 hr, virus was removed and G418
(50 mg/ml) was applied for 2 weeks. After 2 weeks, colonies were
manually picked and transferred to fresh MEF feeder cells in 96-
well plates. Genomic DNA extracted from G418R clones was
analyzed using Southern blot analysis with probes to the left
(probe 1) and right (probe 2) homology arms.
Neural Differentiation and NPC Culture
Methods to derive and passage NPCs are described in detail in the
Supplemental Experimental Procedures. Briefly, embryoid bodies
formed over 5 days in the presence of 50 ng/ml recombinant
mouse noggin (R&D Systems) and 0.5 mM Dorsomorphin (Tocris
Bioscience) were cultured in neural induction media. After
7 days, neural rosettes were isolated, dissociated into single cells,
and plated onto poly-L-ornithine (10 mg/ml) and mouse laminin
(5 mg/ml)-coated dishes in neural induction media with 10 ng/ml
mouse FGF2 and 10 ng/ml mouse EGF2.
Endodermal Differentiation
Methods to differentiate hESCs to endodermal derivatives are
described in detail in the Supplemental Experimental Procedures.
Briefly, to generate DE, hESCs were cultured for 3 days in
100 ng/ml recombinant humanActivin Awith the first day supple-
mented with 30 ng/ml Wnt3a (Willert et al., 2003). For differenti-
ation of AFE, DE cells were treated for 5 days with 200 ng/ml
noggin and 10 mMSB-431542. For differentiation to LPCs, AFE cells
were treated for 5 days with 100 ng/ml Wnt3a, 10 ng/ml mouse
keratinocyte growth factor (KGF/FGF7), 100 ng/ml mouse FGF2,
10 ng/ml mouse BMP4, 10 ng/ml mouse FGF10, and 10 ng/ml
EGF. For differentiation to PFE, DE cells were cultured in 50 ng/ml
KGF for 3 days and then in 50 ng/ml noggin, 0.25 mM 3-keto-N-
(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine, and
2 mM retinoic acid for 3 days.
qRT-PCR
RNA was isolated using TRIzol and reverse transcription was per-
formed by means of qScript cDNA Supermix. qRT-PCR was carried
out using TaqMan probes (Table S3) and TaqMan Fast Universal
PCR Master Mix on a 7900HT Real Time PCR machine. Gene
expression was normalized to 18S rRNA levels. All experiments
were performed with three technical replicates.
IF and FC
Detailed protocols for IF and flow cytometry (FC) are provided in
the Supplemental Information section. For IF, cultures were in
4% (w/v) paraformaldehyde, permeabilized with 0.2% (v/v) Triton
X-100, washed, and incubated overnight in primary antibody. Sec-
ondary antibodies were incubated 1 hr. All antibodies and dilu-
tions are listed in Table S4. Nucleic acids were stained for DNAeports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 475
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SOX2 Expression in Human Pluripotent Stem Cellswith Hoechst 33342 (2 mg/ml). Cells were imaged on an Olympus
Fluoview 1000. Image quantation was performed by counting a
minimum of nine fields at 203 magnification. For FC, cells were
dissociated into single cells with Accutase, washed with fluores-
cence-activated cell sorting (FACS) buffer, resuspended at 5 3 106
cells per 100 ml, stained with indicated antibodies (Table S4), and
analyzed and sorted with a FACSCanto or FACSAria2 (BD Biosci-
ences). FC data were analyzed with FACSDiva software. For replat-
ing experiments, cells were stained with appropriate antibodies,
sorted in FACS buffer, and replated with 10 nM Y27632. Isotype
negative controls are listed in Table S4. For sorting experiments
in which cells were separated on the basis of GFP expression,
wild-type nonfluorescing cells were used as a negative control.
High-Throughput RNA-Seq
RNA-seq of RNA from SOX2-GFP+ and SOX2-GFP AFE cells was
performed as described in the Supplemental Information section,
and differential gene expression analysis was performed with
TopHat and Cufflinks (Trapnell et al., 2012, 2013). Reads per kilo-
base of exon per millionmapped reads (RPKM) were calculated for
each gene and used as an estimate of expression levels.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and four tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2013.09.005.
ACKNOWLEDGMENTS
We would like to thank Eric O’Connor of the UCSD/Sanford Con-
sortium for Regenerative Medicine (SCRM) Human Embryonic
Stem Cell Core for assistance with cell sorting and the SCRM Viral
Vector Core for production of rAAV. D.A.B. was supported by fund-
ing from the UCSD StemCell Program and a gift fromMichael and
Nancy Kaehr. This research was supported in part by the National
Institute of Diabetes and Digestive and Kidney Diseases Beta Cell
Biology Consortium (5U01DK089567-02) and the California Insti-
tute for Regenerative Medicine (RT2-02064). This work was made
possible in part by the CIRM Major Facilities grant (FA1-00607)
to the Sanford Consortium for Regenerative Medicine.
Received: May 22, 2013
Revised: September 24, 2013
Accepted: September 25, 2013
Published: October 31, 2013REFERENCES
Arnold, K., Sarkar, A., Yram, M.A., Polo, J.M., Bronson, R.,
Sengupta, S., Seandel, M., Geijsen, N., and Hochedlinger, K.
(2011). Sox2(+) adult stem and progenitor cells are important for
tissue regeneration and survival ofmice. Cell StemCell 9, 317–329.
Asuri, P., Bartel,M.A., Vazin, T., Jang, J.H.,Wong, T.B., and Schaffer,
D.V. (2012). Directed evolution of adeno-associated virus for
enhanced gene delivery and gene targeting in human pluripotent
stem cells. Mol. Ther. 20, 329–338.476 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 TheAvilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and
Lovell-Badge, R. (2003). Multipotent cell lineages in early mouse
development depend on SOX2 function. Genes Dev. 17, 126–140.
Buecker, C., Chen, H.H., Polo, J.M., Daheron, L., Bu, L., Barakat,
T.S., Okwieka, P., Porter, A., Gribnau, J., Hochedlinger, K., and
Geijsen, N. (2010). A murine ESC-like state facilitates transgenesis
and homologous recombination in human pluripotent stem cells.
Cell Stem Cell 6, 535–546.
Chambers, S.M., Fasano, C.A., Papapetrou, E.P., Tomishima, M.,
Sadelain, M., and Studer, L. (2009). Highly efficient neural con-
version of human ES and iPS cells by dual inhibition of SMAD
signaling. Nat. Biotechnol. 27, 275–280.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu,
P.D., Wu, X., Jiang, W., Marraffini, L.A., and Zhang, F. (2013).
Multiplex genome engineering using CRISPR/Cas systems. Science
339, 819–823.
Cradick, T.J., Fine, E.J., Antico, C.J., and Bao, G. (2013). CRISPR/
Cas9 systems targeting b-globin and CCR5 genes have substantial
off-target activity. Nucleic Acids Res. Published online August 11,
2013. http://dx.doi.org/10.1093/nar/gkt714.
Dabdoub, A., Puligilla, C., Jones, J.M., Fritzsch, B., Cheah, K.S.,
Pevny, L.H., and Kelley, M.W. (2008). Sox2 signaling in prosensory
domain specification and subsequent hair cell differentiation in
the developing cochlea. Proc. Natl. Acad. Sci. USA 105, 18396–
18401.
Davis, D., and Stokoe, D. (2010). Zinc finger nucleases as tools to
understand and treat human diseases. BMC Med. 8, 42.
Dubois, N.C., Craft, A.M., Sharma, P., Elliott, D.A., Stanley, E.G.,
Elefanty, A.G., Gramolini, A., and Keller, G. (2011). SIRPA is a spe-
cific cell-surface marker for isolating cardiomyocytes derived from
human pluripotent stem cells. Nat. Biotechnol. 29, 1011–1018.
Elkabetz, Y., Panagiotakos, G., Al Shamy, G., Socci, N.D., Tabar, V.,
and Studer, L. (2008). Human ES cell-derived neural rosettes reveal
a functionally distinct early neural stem cell stage. Genes Dev. 22,
152–165.
Ellis, P., Fagan, B.M., Magness, S.T., Hutton, S., Taranova, O.,
Hayashi, S., McMahon, A., Rao, M., and Pevny, L. (2004). SOX2,
a persistent marker for multipotential neural stem cells derived
from embryonic stem cells, the embryo or the adult. Dev. Neurosci.
26, 148–165.
Evseenko, D., Zhu, Y., Schenke-Layland, K., Kuo, J., Latour, B., Ge,
S., Scholes, J., Dravid, G., Li, X.,MacLellan,W.R., andCrooks, G.M.
(2010). Mapping the first stages of mesoderm commitment during
differentiation of human embryonic stem cells. Proc. Natl. Acad.
Sci. USA 107, 13742–13747.
Fagman, H., Amendola, E., Parrillo, L., Zoppoli, P., Marotta, P.,
Scarfo`, M., De Luca, P., de Carvalho, D.P., Ceccarelli, M., De Felice,
M., and Di Lauro, R. (2011). Gene expression profiling at early
organogenesis reveals both common and diverse mechanisms in
foregut patterning. Dev. Biol. 359, 163–175.
Fauquier, T., Rizzoti, K., Dattani, M., Lovell-Badge, R., and Robin-
son, I.C. (2008). SOX2-expressing progenitor cells generate all of
the major cell types in the adult mouse pituitary gland. Proc.
Natl. Acad. Sci. USA 105, 2907–2912.Authors
Stem Cell Reports
SOX2 Expression in Human Pluripotent Stem CellsGraham, V., Khudyakov, J., Ellis, P., and Pevny, L. (2003). SOX2
functions to maintain neural progenitor identity. Neuron 39,
749–765.
Green, M.D., Chen, A., Nostro, M.C., d’Souza, S.L., Schaniel, C.,
Lemischka, I.R., Gouon-Evans, V., Keller, G., and Snoeck, H.W.
(2011). Generation of anterior foregut endoderm from human
embryonic and induced pluripotent stem cells. Nat. Biotechnol.
29, 267–272.
Hanna, J., Cheng, A.W., Saha, K., Kim, J., Lengner, C.J., Soldner, F.,
Cassady, J.P., Muffat, J., Carey, B.W., and Jaenisch, R. (2010).
Human embryonic stem cells with biological and epigenetic char-
acteristics similar to those ofmouse ESCs. Proc. Natl. Acad. Sci. USA
107, 9222–9227.
Hirata, R., Chamberlain, J., Dong, R., and Russell, D.W. (2002).
Targeted transgene insertion into human chromosomes by
adeno-associated virus vectors. Nat. Biotechnol. 20, 735–738.
Hockemeyer, D., Wang, H., Kiani, S., Lai, C.S., Gao, Q., Cassady,
J.P., Cost, G.J., Zhang, L., Santiago, Y., Miller, J.C., et al. (2011).
Genetic engineering of human pluripotent cells using TALE nucle-
ases. Nat. Biotechnol. 29, 731–734.
Hou, Z., Zhang, Y., Propson, N.E., Howden, S.E., Chu, L.F.,
Sontheimer, E.J., and Thomson, J.A. (2013). Efficient genome engi-
neering in human pluripotent stem cells using Cas9 fromNeisseria
meningitidis. Proc. Natl. Acad. Sci. USA 110, 15644–15649.
Kelly, O.G., Chan, M.Y., Martinson, L.A., Kadoya, K., Ostertag,
T.M., Ross, K.G., Richardson, M., Carpenter, M.K., D’Amour,
K.A., Kroon, E., et al. (2011). Cell-surface markers for the isolation
of pancreatic cell types derived from human embryonic stem cells.
Nat. Biotechnol. 29, 750–756.
Khan, I.F., Hirata, R.K., Wang, P.R., Li, Y., Kho, J., Nelson, A., Huo,
Y., Zavaljevski, M., Ware, C., and Russell, D.W. (2010). Engineering
of human pluripotent stem cells by AAV-mediated gene targeting.
Mol. Ther. 18, 1192–1199.
Khan, I.F., Hirata, R.K., and Russell, D.W. (2011). AAV-mediated
gene targeting methods for human cells. Nat. Protoc. 6, 482–501.
Kiefer, J.C. (2007). Back to basics: Sox genes. Dev. Dyn. 236, 2356–
2366.
Kiernan, A.E., Pelling, A.L., Leung, K.K., Tang, A.S., Bell, D.M.,
Tease, C., Lovell-Badge, R., Steel, K.P., and Cheah, K.S. (2005).
Sox2 is required for sensory organ development in themammalian
inner ear. Nature 434, 1031–1035.
Lefebvre, V., Dumitriu, B., Penzo-Me´ndez, A., Han, Y., and Pallavi,
B. (2007). Control of cell fate and differentiation by Sry-related
high-mobility-group box (Sox) transcription factors. Int. J.
Biochem. Cell Biol. 39, 2195–2214.
Li, W., Sun, W., Zhang, Y., Wei, W., Ambasudhan, R., Xia, P.,
Talantova, M., Lin, T., Kim, J., Wang, X., et al. (2011). Rapid induc-
tion and long-term self-renewal of primitive neural precursors
from human embryonic stem cells by small molecule inhibitors.
Proc. Natl. Acad. Sci. USA 108, 8299–8304.
Longmire, T.A., Ikonomou, L., Hawkins, F., Christodoulou, C.,
Cao, Y., Jean, J.C., Kwok, L.W., Mou, H., Rajagopal, J., Shen, S.S.,
et al. (2012). Efficient derivation of purified lung and thyroid pro-
genitors from embryonic stem cells. Cell Stem Cell 10, 398–411.Stem Cell RLorthongpanich, C., Yang, S.H., Piotrowska-Nitsche, K., Parnpai,
R., and Chan, A.W. (2008). Development of single mouse blasto-
meres into blastocysts, outgrowths and the establishment of
embryonic stem cells. Reproduction 135, 805–813.
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E.,
Norville, J.E., and Church, G.M. (2013). RNA-guided human
genome engineering via Cas9. Science 339, 823–826.
Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disrup-
tion of the proto-oncogene int-2 in mouse embryo-derived stem
cells: a general strategy for targeting mutations to non-selectable
genes. Nature 336, 348–352.
McKnight, K.D., Wang, P., and Kim, S.K. (2010). Deconstructing
pancreas development to reconstruct human islets from pluripo-
tent stem cells. Cell Stem Cell 6, 300–308.
Mou, H., Zhao, R., Sherwood, R., Ahfeldt, T., Lapey, A., Wain, J.,
Sicilian, L., Izvolsky, K., Musunuru, K., Cowan, C., and Rajagopal,
J. (2012). Generation of multipotent lung and airway progenitors
from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell
Stem Cell 10, 385–397.
Nichols, J., and Smith, A. (2009). Naive and primed pluripotent
states. Cell Stem Cell 4, 487–492.
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius,
D., Chambers, I., Scho¨ler, H., and Smith, A. (1998). Formation of
pluripotent stem cells in the mammalian embryo depends on
the POU transcription factor Oct4. Cell 95, 379–391.
Okubo, T., Pevny, L.H., andHogan, B.L. (2006). Sox2 is required for
development of taste bud sensory cells. Genes Dev. 20, 2654–2659.
Que, J., Okubo, T., Goldenring, J.R., Nam, K.T., Kurotani, R.,
Morrisey, E.E., Taranova, O., Pevny, L.H., and Hogan, B.L. (2007).
Multiple dose-dependent roles for Sox2 in the patterning and
differentiation of anterior foregut endoderm. Development 134,
2521–2531.
Que, J., Luo, X., Schwartz, R.J., and Hogan, B.L. (2009). Multiple
roles for Sox2 in the developing and adultmouse trachea. Develop-
ment 136, 1899–1907.
Radecke, S., Radecke, F., Cathomen, T., and Schwarz, K. (2010).
Zinc-finger nuclease-induced gene repair with oligodeoxynucleo-
tides: wanted and unwanted target locus modifications. Mol.
Ther. 18, 743–753.
Rizzino, A. (2009). Sox2 and Oct-3/4: a versatile pair of master
regulators that orchestrate the self-renewal and pluripotency of
embryonic stem cells. Wiley Interdiscip. Rev. Syst. Biol. Med. 1,
228–236.
Rossant, J. (2004). Lineage development and polar asymmetries in
the peri-implantation mouse blastocyst. Semin. Cell Dev. Biol. 15,
573–581.
Saliem, M., Ericzon, B.G., Ellis, E., Hovatta, O., and Go¨therstro¨m,
C. (2012). Isolation and characterization of mesenchymal stem
cells from human fetal liver; potential candidates for replacement
therapy in liver disease. J. Liver: Dis. Transplant. 1, 2.
Shin, S., Mitalipova, M., Noggle, S., Tibbitts, D., Venable, A., Rao,
R., and Stice, S.L. (2006). Long-termproliferation of human embry-
onic stem cell-derived neuroepithelial cells using defined adherent
culture conditions. Stem Cells 24, 125–138.eports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 The Authors 477
Stem Cell Reports
SOX2 Expression in Human Pluripotent Stem CellsSmith-Arica, J.R., Thomson, A.J., Ansell, R., Chiorini, J., Davidson,
B., and McWhir, J. (2003). Infection efficiency of human and
mouse embryonic stem cells using adenoviral and adeno-associ-
ated viral vectors. Cloning Stem Cells 5, 51–62.
Song, H., Chung, S.K., and Xu, Y. (2010). Modeling disease in
human ESCs using an efficient BAC-based homologous recombi-
nation system. Cell Stem Cell 6, 80–89.
Stewart, M.H., Bosse´, M., Chadwick, K., Menendez, P., Bendall,
S.C., and Bhatia, M. (2006). Clonal isolation of hESCs reveals
heterogeneity within the pluripotent stem cell compartment.
Nat. Methods 3, 807–815.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T.,
Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent
stem cells from adult human fibroblasts by defined factors. Cell
131, 861–872.
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R.,
Pimentel, H., Salzberg, S.L., Rinn, J.L., and Pachter, L. (2012).
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562–578.
Trapnell, C., Hendrickson, D.G., Sauvageau,M., Goff, L., Rinn, J.L.,
and Pachter, L. (2013). Differential analysis of gene regulation at
transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46–53.478 Stem Cell Reports j Vol. 1 j 464–478 j November 19, 2013 j ª2013 TheWang, J., Rao, S., Chu, J., Shen, X., Levasseur, D.N., Theunissen,
T.W., and Orkin, S.H. (2006). A protein interaction network for
pluripotency of embryonic stem cells. Nature 444, 364–368.
Wang, P., Rodriguez, R.T., Wang, J., Ghodasara, A., and Kim, S.K.
(2011). Targeting SOX17 in human embryonic stem cells creates
unique strategies for isolating and analyzing developing endo-
derm. Cell Stem Cell 8, 335–346.
Willert, K., Brown, J.D., Danenberg, E., Duncan, A.W., Weissman,
I.L., Reya, T., Yates, J.R., 3rd, and Nusse, R. (2003). Wnt proteins
are lipid-modified and can act as stem cell growth factors. Nature
423, 448–452.
Yuan, S.H., Martin, J., Elia, J., Flippin, J., Paramban, R.I., Hefferan,
M.P., Vidal, J.G.,Mu, Y., Killian, R.L., Israel,M.A., et al. (2011). Cell-
surface marker signatures for the isolation of neural stem cells, glia
and neurons derived from human pluripotent stem cells. PLoS
ONE 6, e17540.
Zou, J., Maeder, M.L., Mali, P., Pruett-Miller, S.M., Thibodeau-
Beganny, S., Chou, B.K., Chen, G., Ye, Z., Park, I.H., Daley, G.Q.,
et al. (2009). Gene targeting of a disease-related gene in human
induced pluripotent stem and embryonic stem cells. Cell Stem
Cell 5, 97–110.Authors
